14-3-3β regulates the proliferation of glioma cells through the GSK3β/β-catenin signaling pathway

Oncology Reports

Volumn 30, Issue 6, 2013, Pages 2976-2982

  Gong, Fanghe ^a   Wang, Guoliang ^a   Ye, Jing ^b   Li, Tiandong ^a   Bai, Hongmin ^a   Wang, Weimin ^a  

^a GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

catenin; 14 3 3 ; Astrocytoma; Cell proliferation; GSK3

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIBODY; BETA CATENIN; BROXURIDINE; CYCLIN D1; FLAG ANTIBODY; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN 14 3 3; PROTEIN 14 3 3 BETA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANTIBODY LABELING; ARTICLE; ASTROCYTE; ASTROCYTOMA; BRDU ASSAY; CANCER CELL CULTURE; CARCINOGENESIS; CELL ASSAY; CELL PROLIFERATION; CELL STRAIN SVGP12; CELL STRAIN U87; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SILENCING; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MTT ASSAY; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN NUCLEAR TRANSLOCATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR GROWTH; WESTERN BLOTTING;

14-3-3 PROTEINS; ASTROCYTOMA; BETA CATENIN; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; GLYCOGEN SYNTHASE KINASE 3; HUMANS; SIGNAL TRANSDUCTION;

EID: 84892387506     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2740     Document Type: Article

References (54)

1. van Hemert MJ, Steensma HY and van Heusden GP: 14-3-3 proteins: key regulators of cell division, signalling and apoptosis. Bioessays 23: 936-946, 2001.
2. Baldin V: 14-3-3 proteins and growth control. Prog Cell Cycle Res 4: 49-60, 2000.
3. Fu H, Subramanian RR and Masters SC: 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 40: 617-647, 2000.
4. Aitken A: Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants. Plant Mol Biol 50: 993-1010, 2002.
5. Hermeking H: The 14-3-3 cancer connection. Nat Rev Cancer 3: 931-943, 2003.
6. Wilker E and Yaffe MB: 14-3-3 proteins - a focus on cancer and human disease. J Mol Cell Cardiol 37: 633-642, 2004.
7. Tzivion G, Gupta VS, Kaplun L and Balan V: 14-3-3 proteins as potential oncogenes. Semin Cancer Biol 16: 203-213, 2006.
8. Neal CL, Yao J, Yang W, et al: 14-3-3ζ overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival. Cancer Res 69: 3425-3432, 2009.
9. Neal CL, Xu J, Li P, et al: Overexpression of 14-3-3ζ in cancer cells activates PI3K via binding the p85 regulatory subunit. Oncogene 31: 897-906, 2012.
10. Zang D, Li X and Zhang L: 14-3-3ζ overexpression and abnormal β-catenin expression are associated with poor differentiation and progression in stage I non-small cell lung cancer. Clin Exp Med 10: 221-228, 2010.
11. Li Z, Zhao J, Du Y, et al: Down-regulation of 14-3-3ζ suppresses anchorage-independent growth of lung cancer cells through anoikis activation. Proc Natl Acad Sci USA 105: 162-167, 2008.
12. Luo J, Feng J, Lu J, et al: Aberrant methylation profile of 14-3-3 sigma and its reduced transcription/expression levels in Chinese sporadic female breast carcinogenesis. Med Oncol 27: 791-797, 2010.
13. Frasor J, Chang EC, Komm B, et al: Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. Cancer Res 66: 7334-7340, 2006.
14. Sun B, Zhang S, Zhang D, et al: Identification of metastasis-related proteins and their clinical relevance to triple-negative human breast cancer. Clin Cancer Res 14: 7050-7059, 2008.
15. Ramirez JL, Rosell R, Taron M, et al: 14-3-3σ methylation in pretreatment serum circulating DNA of cisplatinplus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: the Spanish Lung Cancer Group. J Clin Oncol 23: 9105-9112, 2005.
16. Muslin AJ and Xing H: 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cell Signal 12: 703-709, 2000.
17. Pawson T and Nash P: Protein-protein interactions define specificity in signal transduction. Genes Dev 14: 1027-1047, 2000.
18. Chohan G, Pennington C, Mackenzie JM, et al: The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. J Neurol Neurosurg Psychiatry 81: 1243-1248, 2010.
19. Ladogana A, Sanchez-Juan P, Mitrova E, et al: Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies. J Neurol 256: 1620-1628, 2009.
20. Larska M, Polak MP, Zmudzinski JF and Torres JM: Comparison of mRNA expression levels of selected genes in the brain stem of cattle naturally infected with classical and atypical BSE. Brain Res 1351: 13-22, 2010.
21. Cao L, Cao W, Zhang W, et al: Identification of 14-3-3 protein isoforms in human astrocytoma by immunohistochemistry. Neurosci Lett 432: 94-99, 2008.
22. Yang X, Cao W, Lin H, et al: Isoform-specific expression of 14-3-3 proteins in human astrocytoma. J Neurol Sci 276: 54-59, 2009.
23. Mwangi S, Anitha M, Fu H, Sitaraman SV and Srinivasan S: Glial cell line-derived neurotrophic factor-mediated enteric neuronal survival involves glycogen synthase kinase-3β phosphorylation and coupling with 14-3-3. Neuroscience 143: 241-251, 2006.
24. Doble BW and Woodgett JR: GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116: 1175-1186, 2003.
25. Grimes CA and Jope RS: The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 65: 391-426, 2001.
26. Ciani L and Salinas PC: WNTs in the vertebrate nervous system: from patterning to neuronal connectivity. Nat Rev Neurosci 6: 351-362, 2005.
27. Polakis P: The oncogenic activation of β-catenin. Curr Opin Genet Dev 9: 15-21, 1999.
28. Mulholland DJ, Dedhar S, Wu H and Nelson CC: PTEN and GSK3β: key regulators of progression to androgen-independent prostate cancer. Oncogene 25: 329-337, 2006.
29. Kotliarova S, Pastorino S, Kovell LC, et al: Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-κB, and glucose regulation. Cancer Res 68: 6643-6651, 2008.
30. Davis FG, McCarthy BJ, Freels S, Kupelian V and Bondy ML: The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data. Cancer 85: 485-491, 1999.
31. DeAngelis LM: Brain tumors. N Engl J Med 344: 114-123, 2001.
32. van den Bent MJ, Hegi ME and Stupp R: Recent developments in the use of chemotherapy in brain tumours. Eur J Cancer 42: 582-588, 2006.
33. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001.
34. Krieghoff E, Behrens J and Mayr B: Nucleo-cytoplasmic distribution of β-catenin is regulated by retention. J Cell Sci 119: 1453-1463, 2006.
35. Polakis P: Wnt signaling in cancer. Cold Spring Harb Perspect Biol 4: pii: a008052, 2012. doi: 10.1101/cshperspect.a008052.
36. Han DC, Rodriguez LG and Guan JL: Identification of a novel interaction between integrin β1 and 14-3-3β. Oncogene 20: 346-357, 2001.
37. Toshima JY, Toshima J, Watanabe T and Mizuno K: Binding of 14-3-3β regulates the kinase activity and subcellular localization of testicular protein kinase 1. J Biol Chem 276: 43471-43481, 2001.
38. Wang Y, Jacobs C, Hook KE, et al: Binding of 14-3-3β to the carboxyl terminus of Wee1 increases Wee1 stability, kinase activity, and G2-M cell population. Cell Growth Differ 11: 211-219, 2000.
39. Takihara Y, Matsuda Y and Hara J: Role of the β isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation. Carcinogenesis 21: 2073-2077, 2000.
40. Sugiyama A, Miyagi Y, Komiya Y, et al: Forced expression of antisense 14-3-3β RNA suppresses tumor cell growth in vitro and in vivo. Carcinogenesis 24: 1549-1559, 2003.
41. Musholt TJ, Brehm C, Hanack J, von Wasielewski R and Musholt PB: Identification of differentially expressed genes in papillary thyroid carcinomas with and without rearrangements of the tyrosine kinase receptors RET and/or NTRK1. J Surg Res 131: 15-25, 2006.
42. Zeng Y, Li Y, Chen RS, et al: Overexpression of xCT induces up-regulation of 14-3-3β in Kaposi's sarcoma. Biosci Rep 30: 277-283, 2010.
43. Qi W, Liu X, Qiao D and Martinez JD: Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int J Cancer 113: 359-363, 2005.
44. Chiang CW, Harris G, Ellig C, et al: Protein phosphatase 2A activates the proapoptotic function of BAD in interleukin-3-dependent lymphoid cells by a mechanism requiring 14-3-3 dissociation. Blood 97: 1289-1297, 2001.
45. Kockeritz L, Doble B, Patel S and Woodgett JR: Glycogen synthase kinase-3 - an overview of an over-achieving protein kinase. Curr Drug Targets 7: 1377-1388, 2006.
46. Kaidanovich-Beilin O, Milman A, Weizman A, Pick CG and Eldar-Finkelman H: Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β-catenin in mouse hippocampus. Biol Psychiatry 55: 781-784, 2004.
47. Li J, Mizukami Y, Zhang X, Jo WS and Chung DC: Oncogenic K-ras stimulates Wnt signaling in colon cancer through inhibition of GSK-3β. Gastroenterology 128: 1907-1918, 2005.
48. Welsh GI and Proud CG: Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem J 294: 625-629, 1993.
49. Berg D, Holzmann C and Riess O: 14-3-3 proteins in the nervous system. Nat Rev Neurosci 4: 752-762, 2003.
50. Mhawech P: 14-3-3 proteins - an update. Cell Res 15: 228-236, 2005.
51. Chang TC, Liu CC, Hsing EW, et al: 14-3-3σ regulates β-catenin-mediated mouse embryonic stem cell proliferation by sequestering GSK-3β. PLoS One 7: e40193, 2012.
52. Goñi-Oliver P, Avila J and Hernández F: Calpain regulates N-terminal interaction of GSK-3β with 14-3-3ζ, p53 and PKB but not with axin. Neurochem Int 59: 97-100, 2011.
53. Gurusamy N, Watanabe K, Ma M, et al: Glycogen synthase kinase 3β together with 14-3-3 protein regulates diabetic cardiomyopathy: effect of losartan and tempol. FEBS Lett 580: 1932-1940, 2006.
54. Kikuchi A, Yamamoto H, Sato A and Matsumoto S: New insights into the mechanism of Wnt signaling pathway activation. Int Rev Cell Mol Biol 291: 21-71, 2011.